Clinical Trial Update: Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating peptide vaccinations in patients with low-risk myeloid cancers, including myelodysplastic syndrome and acute myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) | Phase 2 | Status: COMPLETED | Results posted: 2014-07-09